[Federal Register Volume 59, Number 146 (Monday, August 1, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-18604]


[[Page Unknown]]

[Federal Register: August 1, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army

 

Availability of Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Monoclonal Antibodies to 
Cholesterol and Methods

AGENCY: U.S. Army Medical Research and Development Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability of U.S. patent No. 4,885,256, entitled ``Monoclonal 
Antibodies to Cholesterol and Methods'' issued December 5, 1989 for 
licensing. This patent has been assigned to the United States 
Government as represented by the Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research, Development, 
Acquisitions and Logistics Command, ATTN: Staff Judge Advocate, Fort 
Detrick, Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT:
Mr. John F. Moran, Patent Attorney (301) 619-2065 or telfax (301) 619-
7714.

SUPPLEMENTARY INFORMATION: the invention encompassed by this patent 
involves monoclonal antibodies to cholesterol and methods for the 
detection of high levels of cholesterol by contacting biological 
specimens containing cholesterol with the monoclonal antibodies and 
measuring the formation of antigen-antibody complexes by immunosorbent 
assay.
Kenneth L. Denton,
Army Federal Register Liaison Officer.
[FR Doc. 94-18604 Filed 7-29-94; 8:45 am]
BILLING CODE 3710-08-M